Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...

Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as ...

A new blood test is designed to find mold infections deep inside the body, sparing patients from tissue biopsies.

Spanish start-up Amadix has received €15m ($15.4m) in financing from the European Investment Bank (EIB) to advance the ...

Amadix, a Spanish biotech company focused on non-invasive blood tests for early cancer detection, has secured a €15 million loan from the Europ ...

Know about the revolutionary therapies, personalised medicine and cancer treatments that are changing the game!

TLT has advised a Glasgow-based diagnostics company that has pioneered the early detection and identification of cancer on a ...

Explore how genetic testing and precision oncology are revolutionizing cancer treatment by offering personalized care and ...

Liquid Biopsy MarketThe global liquid biopsy market is poised for substantial expansion, with an estimated revenue of USD 1,538.3 million in 2023. The market is projected to grow at an impressive ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.

Raymond Cheslock, a father of two, was diagnosed with leukemia in 2019. After undergoing a round of chemotherapy at a ...

Cancer Check Labs is live in 44 states and has the ability to test for any solid tumor with a 40 ml blood draw.